Find your program — matched from the ledger, labels attached

Most "quizzes" in this market are funnels to whoever pays best. This one filters our public dataset by your answers, shows every match with its verification status, and explains its reasoning under the results. Our partner can win it — wearing the operator label.

Could insurance realistically cover a brand GLP-1 for you?

Coverage changes everything — an approved drug at a copay beats every cash price below.

What's your real monthly ceiling?

Be honest about month twelve, not month one.

What matters more?

SURMOUNT-5: tirzepatide averaged 20.2% vs semaglutide's 13.7% — but semaglutide is cheaper.

Injections?

Injectable is the only format with tirzepatide trial evidence. Approved pills exist — for other molecules.

Would you commit 12 months for a lower rate?

Annual plans cut $20–40/mo — and only pay off if terms hold and you stay.

Pick your tiebreaker.

This decides how we rank ties.

Answer all six and your matches render here.